Therapeutics News

Autologous skin cell suspension transplantation using a cell harvesting device was shown to be effective and well tolerated in vitiligo treatment, according to a study.

Zasocitinib, a potent and selective tyrosine kinase 2 inhibitor, safely and effectively cleared psoriasis in a high proportion of patients, according to a study.

The FDA has cleared an investigational new drug application for a first-in-human phase 1/2 study of ATR-04 for moderate to severe dermal toxicity from epidermal growth factor receptor inhibitors, Azitra Inc. announced in a press release.

The FDA has approved a pediatric indication for NexoBrid for the treatment of deep partial-thickness and full-thickness thermal burns, Vericel Corporation announced in a press release.

The lack of surgical instruments tailored for women’s hands is just one example of the gender inequity female surgeons face in the workforce.

The FDA approved Nemluvio in the form of a prefilled pen for subcutaneous injection for the treatment of prurigo nodularis in adults, Galderma announced in a press release.

Optical coherence tomography may be able to guide treatment for port wine birthmarks that show wide variability in vessel density and size, but improvements are needed, according to a study.

Dermatologic surgery wounds that were exposed to water in the hours following surgery did not experience an increase in infection, hematoma or bruising, according to a study.

Healio has compiled July’s most-read news in dermatology.